Journal: Frontiers in Pharmacology
Article Title: Computational drug repurposing in Parkinson’s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
doi: 10.3389/fphar.2025.1539032
Figure Lengend Snippet: (A) Twenty-eight PD drug candidates with neuroprotective effects. PMID stands for Specific Literature Evidence of Prior Neuroprotective Effects of the Drug. Evidence is categorized into in vivo and in vitro representations. Nine drug candidates have been shown to have neurocellular protective effects in vivo and in vitro . (B–I) CCK8 experiments validate effects of drug candidates on SH-SY5Y cells. Above are the results of testing the activity of eight drugs on MPTP-induced SH-SY5Y cells. All data are presented as mean ± SEM, n = 3. The eight drugs in order were Paliperidone, Lcz696, Nicardipine, Almitrine, Omaveloxolone, Aliskiren, Cyproheptadine and Pizotifen. ## P < 0.01 compared with the control group. * P < 0.05 and ** P < 0.01 compared with the MPTP group.
Article Snippet: Paliperidone, Lcz696, Nicardipine, Almitrine, Omaveloxolone, Aliskiren, Cyproheptadine and Pizotifen were purchased from Selleck (Shanghai, China), dissolved in 2% dimethyl sulfoxide (DMSO) and diluted with 0.9% saline to a stock solution.
Techniques: In Vivo, In Vitro, Activity Assay, Control